Celator Pharmaceuticals, Inc. Announces Appointment Of Derek Miller As Chief Business Officer

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

EWING, N.J., Dec. 3, 2013 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced the appointment of Derek Miller as Chief Business Officer. Miller will be responsible for corporate development of the company, including the commercialization of existing product opportunities, exploring new opportunities for clinical stage assets, business development initiatives, and general management responsibilities.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC